What is Castle Biosciences's PP&E sale proceeds?

Castle Biosciences (CSTL) reported PP&E sale proceeds of $7K in Q1 2026.

How has Castle Biosciences's PP&E sale proceeds changed year-over-year?

Castle Biosciences's PP&E sale proceeds decreased by 22.2% year-over-year, from $9K to $7K.

What is the long-term trend for Castle Biosciences's PP&E sale proceeds?

Over 3 years (2022 to 2025), Castle Biosciences's PP&E sale proceeds has grown at a -38.7% compound annual growth rate (CAGR), from $195K to $45K.

What does PP&E sale proceeds mean?

Cash received from selling property, plant, and equipment no longer needed for operations.

Castle Biosciences CSTL PP&E Sale Proceeds

PP&E Sale Proceeds at other companies

Labcorp HoldingsLH

$7.8M+1,460%

Personalis, Inc.PSNL

$120K—

Fulgent Genetics, Inc.FLGT

$8K+300%

Other financials

Income statement

See full

Revenue$83.7M-4.9%

Gross profit$63.1M-11.8%

Operating income-$18.4M+34.1%

Net income-$14.5M+43.8%

EPS (diluted)-$0.49+45.6%

Balance sheet

See full

Cash & equivalents$63.8M-28.9%

Total debt$36.7M+42.1%

Total equity$461.4M+4.8%

Total assets$547.8M+9.2%

Cash flow

See full

Operating cash flow-$22.1M-267%

CapEx$12.5M+163%

Free cash flow-$34.6M-221%

Valuation

See full

Market cap$694.86M+29.9%

Enterprise value$667.82M+41.8%

P/S2×+0.5×

Profitability

See full

Gross margin77.9%-4.1pp

Operating margin-9.8%-30.8pp

Net margin-3.8%-10.2pp

FCF margin1.3%-10.7pp

Returns & leverage

See full

Return on equity-2.8%-10.6pp

Debt / equity0.1×0.0×

Current ratio6.7×-2.6×

Where this comes from

Reported directly by Castle Biosciences in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment.

The official record: Castle Biosciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Castle Biosciences's pp&e sale proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Castle Biosciences's PP&E sale proceeds?: Castle Biosciences (CSTL) reported PP&E sale proceeds of $7K in Q1 2026.
How has Castle Biosciences's PP&E sale proceeds changed year-over-year?: Castle Biosciences's PP&E sale proceeds decreased by 22.2% year-over-year, from $9K to $7K.
What is the long-term trend for Castle Biosciences's PP&E sale proceeds?: Over 3 years (2022 to 2025), Castle Biosciences's PP&E sale proceeds has grown at a -38.7% compound annual growth rate (CAGR), from $195K to $45K.
What does PP&E sale proceeds mean?: Cash received from selling property, plant, and equipment no longer needed for operations.